Clinical Trial Update: Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy With and Without Bevacizumab as First-Line Treatment of Subjects With Advanced Cervical Cancer (FERMATA) [Phase 3]

View source ↗

Summary

Phase 3 trial updating efficacy and safety of BCD-100 (Anti-PD-1) with platinum-based chemotherapy with/without bevacizumab as first-line treatment for advanced…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• BCD-100 (unclear)

Snippet

Sponsor: Biocad | Conditions: Cervical Cancer | Phase 3 | Status: UNKNOWN